tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Veritas In Silico Files Patent for First-in-Class mRNA-Targeted Drug for Post-Surgery Kidney Injury
PremiumCompany AnnouncementsVeritas In Silico Files Patent for First-in-Class mRNA-Targeted Drug for Post-Surgery Kidney Injury
2M ago
Veritas In Silico’s Strategic Shift Towards Specialty Pharma
Premium
Company Announcements
Veritas In Silico’s Strategic Shift Towards Specialty Pharma
2M ago
Veritas In Silico Secures Patent for Innovative Drug Delivery System
Premium
Company Announcements
Veritas In Silico Secures Patent for Innovative Drug Delivery System
2M ago
Veritas In Silico and Dexerials Collaborate on Advanced RNA Measurement Technology
PremiumCompany AnnouncementsVeritas In Silico and Dexerials Collaborate on Advanced RNA Measurement Technology
3M ago
Veritas In Silico Revises FY2025 Financial Forecast Amid Contract Delays
Premium
Company Announcements
Veritas In Silico Revises FY2025 Financial Forecast Amid Contract Delays
4M ago
Veritas In Silico to Relocate Shin-Kawasaki Research Institute
Premium
Company Announcements
Veritas In Silico to Relocate Shin-Kawasaki Research Institute
5M ago
Veritas In Silico Launches First In-House Nucleic Acid Drug Project
PremiumCompany AnnouncementsVeritas In Silico Launches First In-House Nucleic Acid Drug Project
8M ago
Veritas In Silico and Shionogi Achieve Milestone in mRNA-targeted Drug Discovery
Premium
Company Announcements
Veritas In Silico and Shionogi Achieve Milestone in mRNA-targeted Drug Discovery
9M ago
Veritas In Silico Inc. Reports Q1 2025 Financial Results
Premium
Company Announcements
Veritas In Silico Inc. Reports Q1 2025 Financial Results
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100